Titlebook: Artificial Intelligence and Precision Oncology; Bridging Cancer Rese Zodwa Dlamini Book 2023 The Editor(s) (if applicable) and The Author(s

热爱

书目名称Artificial Intelligence and Precision Oncology影响因子(影响力)




书目名称Artificial Intelligence and Precision Oncology影响因子(影响力)学科排名




书目名称Artificial Intelligence and Precision Oncology网络公开度




书目名称Artificial Intelligence and Precision Oncology网络公开度学科排名




书目名称Artificial Intelligence and Precision Oncology被引频次




书目名称Artificial Intelligence and Precision Oncology被引频次学科排名




书目名称Artificial Intelligence and Precision Oncology年度引用




书目名称Artificial Intelligence and Precision Oncology年度引用学科排名




书目名称Artificial Intelligence and Precision Oncology读者反馈




书目名称Artificial Intelligence and Precision Oncology读者反馈学科排名

创新

978-3-031-21508-7The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl

Postulate

细颈瓶

http://image.papertrans.cn/b/image/162265.jpg

表示问

https://doi.org/10.1007/3-540-29873-8oring to an individual patient or group of patients would vastly decrease the burden of cancer while ensuring higher rates of patient survival and treatments with less side effects and more success in controlling or eliminating the disease. Precision oncology requires that as much information regard

arthroplasty

不利

https://doi.org/10.1007/3-540-29873-8urrent challenges in cancer treatment include the shortage of expertise, delay in diagnosis, inaccurate quantitative staging and variable treatment response. An improvement in the understanding of the pathogenesis of cancer, tumour microenvironment and metastatic pathways has led to an increase in t

招致

Confirm

https://doi.org/10.1007/3-540-29873-8 prognosis, and treatment. Personalized medicine requires key features to be extracted from large data sets, normally using artificial intelligence (AI). Artificial intelligence can also be used to perform digital pathology and to identify key features in cytology, hematology, and histology based on

合同

https://doi.org/10.1007/3-540-29873-8iptome and proteomic profiles that are unique or more common in cancer. However, it has become obvious that for complex diseases like cancer, it is important and incredibly useful to examine the genetic changes that occur to alter gene expression that do not rely on changes to the genetic sequence.